Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.01
PBH's Cash to Debt is ranked lower than
61% of the 72 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.66 vs. PBH: 0.01 )
PBH' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.01

Equity to Asset 0.23
PBH's Equity to Asset is ranked higher than
55% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. PBH: 0.23 )
PBH' s 10-Year Equity to Asset Range
Min: 0.2   Max: 0.48
Current: 0.23

0.2
0.48
Interest Coverage 2.75
PBH's Interest Coverage is ranked lower than
55% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.02 vs. PBH: 2.75 )
PBH' s 10-Year Interest Coverage Range
Min: 1.69   Max: 9999.99
Current: 2.75

1.69
9999.99
F-Score: 5
Z-Score: 1.30
M-Score: -2.37
WACC vs ROIC
12.34%
6.44%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 28.46
PBH's Operating margin (%) is ranked higher than
97% of the 72 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.54 vs. PBH: 28.46 )
PBH' s 10-Year Operating margin (%) Range
Min: -55.89   Max: 56.28
Current: 28.46

-55.89
56.28
Net-margin (%) 10.49
PBH's Net-margin (%) is ranked higher than
92% of the 72 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. PBH: 10.49 )
PBH' s 10-Year Net-margin (%) Range
Min: -61.61   Max: 29.21
Current: 10.49

-61.61
29.21
ROE (%) 12.17
PBH's ROE (%) is ranked higher than
74% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. PBH: 12.17 )
PBH' s 10-Year ROE (%) Range
Min: -48.3   Max: 14.88
Current: 12.17

-48.3
14.88
ROA (%) 3.23
PBH's ROA (%) is ranked higher than
63% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.22 vs. PBH: 3.23 )
PBH' s 10-Year ROA (%) Range
Min: -20.19   Max: 4.11
Current: 3.23

-20.19
4.11
ROC (Joel Greenblatt) (%) 219.86
PBH's ROC (Joel Greenblatt) (%) is ranked higher than
99% of the 72 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.88 vs. PBH: 219.86 )
PBH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -396.48   Max: 332.66
Current: 219.86

-396.48
332.66
Revenue Growth (3Y)(%) 19.80
PBH's Revenue Growth (3Y)(%) is ranked higher than
88% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. PBH: 19.80 )
PBH' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 84.1
Current: 19.8

0
84.1
EBITDA Growth (3Y)(%) 27.10
PBH's EBITDA Growth (3Y)(%) is ranked higher than
92% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.20 vs. PBH: 27.10 )
PBH' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 59.1
Current: 27.1

0
59.1
EPS Growth (3Y)(%) 33.80
PBH's EPS Growth (3Y)(%) is ranked higher than
90% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. PBH: 33.80 )
PBH' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 230.2
Current: 33.8

0
230.2
» PBH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

PBH Guru Trades in Q1 2014

Joel Greenblatt 289,984 sh (+47.31%)
John Keeley 985,159 sh (+5.57%)
Ken Fisher 1,524,150 sh (+0.19%)
Columbia Wanger 1,740,000 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Ken Heebner Sold Out
Murray Stahl 100,636 sh (-0.75%)
Wallace Weitz 125,000 sh (-16.67%)
» More
Q2 2014

PBH Guru Trades in Q2 2014

Murray Stahl 100,713 sh (+0.08%)
Wallace Weitz 125,000 sh (unchged)
John Keeley 943,159 sh (-4.26%)
Ken Fisher 1,426,675 sh (-6.40%)
Columbia Wanger 754,000 sh (-56.67%)
Joel Greenblatt 48,774 sh (-83.18%)
» More
Q3 2014

PBH Guru Trades in Q3 2014

Paul Tudor Jones 11,918 sh (New)
Joel Greenblatt 420,370 sh (+761.87%)
Wallace Weitz 160,000 sh (+28.00%)
Ken Fisher 1,448,650 sh (+1.54%)
Murray Stahl 100,851 sh (+0.14%)
Columbia Wanger 740,000 sh (-1.86%)
John Keeley 844,159 sh (-10.50%)
» More
Q4 2014

PBH Guru Trades in Q4 2014

Wallace Weitz 160,000 sh (unchged)
John Keeley Sold Out
Ken Fisher 1,446,650 sh (-0.14%)
Murray Stahl 97,227 sh (-3.59%)
Columbia Wanger 674,200 sh (-8.89%)
Paul Tudor Jones 9,076 sh (-23.85%)
Joel Greenblatt 6,728 sh (-98.40%)
» More
» Details

Insider Trades

Latest Guru Trades with PBH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Prestige Brands Holdings Inc

Meridian Funds Comments on Prestige Brands - Sep 08, 2014

Prestige Brands (PBH) is the largest independent provider of over-the-counter products in North America. Examples of their brands include Chloraseptic, Dramamine, PediaCare and Efferdent, to name a few. We added to the position during the first quarter when the stock was one of the largest detractors, selling off for short-term reasons. The company experienced a decline in items stocked at one of the company’s largest customers, but we believe this is a temporary situation and our long- term thesis remains unchanged. This proved timely as the company demonstrated stabilized results during the second quarter and announced an acquisition, which drove the stock higher. Prestige Brands has an asset-light business model that focuses exclusively on the marketing and distribution of these brands, which results in a growing, scalable and high-return business model. We continue to hold the position.

From Meridian Funds (Trades, Portfolio)’ Meridian Growth Fund Second Quarter 2014 Commentary.

Check out Meridian Funds latest stock trades

Top Ranked Articles about Prestige Brands Holdings Inc

Meridian Funds Comments on Prestige Brands
Prestige Brands (PBH) is the largest independent provider of over-the-counter products in North America. Examples of their brands include Chloraseptic, Dramamine, PediaCare and Efferdent, to name a few. We added to the position during the first quarter when the stock was one of the largest detractors, selling off for short-term reasons. The company experienced a decline in items stocked at one of the company’s largest customers, but we believe this is a temporary situation and our long- term thesis remains unchanged. This proved timely as the company demonstrated stabilized results during the second quarter and announced an acquisition, which drove the stock higher. Prestige Brands has an asset-light business model that focuses exclusively on the marketing and distribution of these brands, which results in a growing, scalable and high-return business model. We continue to hold the position. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 33.20
PBH's P/E(ttm) is ranked higher than
63% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 31.10 vs. PBH: 33.20 )
PBH' s 10-Year P/E(ttm) Range
Min: 7.85   Max: 492.31
Current: 33.2

7.85
492.31
Forward P/E 16.03
PBH's Forward P/E is ranked higher than
82% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.00 vs. PBH: 16.03 )
N/A
PE(NRI) 32.90
PBH's PE(NRI) is ranked higher than
68% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 30.80 vs. PBH: 32.90 )
PBH' s 10-Year PE(NRI) Range
Min: 7.93   Max: 426.67
Current: 32.9

7.93
426.67
P/B 3.80
PBH's P/B is ranked higher than
57% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.23 vs. PBH: 3.80 )
PBH' s 10-Year P/B Range
Min: 0.54   Max: 3.8
Current: 3.8

0.54
3.8
P/S 3.40
PBH's P/S is ranked lower than
62% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.07 vs. PBH: 3.40 )
PBH' s 10-Year P/S Range
Min: 0.67   Max: 3.47
Current: 3.4

0.67
3.47
PFCF 17.70
PBH's PFCF is ranked higher than
81% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 2598.00 vs. PBH: 17.70 )
PBH' s 10-Year PFCF Range
Min: 3.11   Max: 20.34
Current: 17.7

3.11
20.34
POCF 17.18
PBH's POCF is ranked higher than
76% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.58 vs. PBH: 17.18 )
PBH' s 10-Year POCF Range
Min: 3.08   Max: 17.37
Current: 17.18

3.08
17.37
EV-to-EBIT 20.33
PBH's EV-to-EBIT is ranked higher than
76% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.97 vs. PBH: 20.33 )
PBH' s 10-Year EV-to-EBIT Range
Min: -4.3   Max: 20.7
Current: 20.33

-4.3
20.7
Shiller P/E 223.00
PBH's Shiller P/E is ranked higher than
60% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 104.93 vs. PBH: 223.00 )
PBH' s 10-Year Shiller P/E Range
Min: 165.3   Max: 878.5
Current: 223

165.3
878.5
Current Ratio 2.21
PBH's Current Ratio is ranked higher than
83% of the 72 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.52 vs. PBH: 2.21 )
PBH' s 10-Year Current Ratio Range
Min: 1.7   Max: 3.98
Current: 2.21

1.7
3.98
Quick Ratio 1.38
PBH's Quick Ratio is ranked higher than
82% of the 72 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.08 vs. PBH: 1.38 )
PBH' s 10-Year Quick Ratio Range
Min: 1.08   Max: 3.05
Current: 1.38

1.08
3.05
Days Inventory 88.47
PBH's Days Inventory is ranked higher than
68% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.87 vs. PBH: 88.47 )
PBH' s 10-Year Days Inventory Range
Min: 45.4   Max: 87.68
Current: 88.47

45.4
87.68
Days Sales Outstanding 45.99
PBH's Days Sales Outstanding is ranked higher than
77% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 63.53 vs. PBH: 45.99 )
PBH' s 10-Year Days Sales Outstanding Range
Min: 38.2   Max: 65.31
Current: 45.99

38.2
65.31

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.80
PBH's Dividend Yield is ranked lower than
87% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.58 vs. PBH: 0.80 )
PBH' s 10-Year Dividend Yield Range
Min: 0.87   Max: 1.18
Current: 0.8

0.87
1.18
Yield on cost (5-Year) 0.80
PBH's Yield on cost (5-Year) is ranked lower than
87% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.90 vs. PBH: 0.80 )
PBH' s 10-Year Yield on cost (5-Year) Range
Min: 0.87   Max: 1.18
Current: 0.8

0.87
1.18
Share Buyback Rate -1.30
PBH's Share Buyback Rate is ranked higher than
66% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.60 vs. PBH: -1.30 )
PBH' s 10-Year Share Buyback Rate Range
Min: 0   Max: -23.5
Current: -1.3

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 9.90
PBH's Price/DCF (Projected) is ranked higher than
62% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.20 vs. PBH: 9.90 )
PBH' s 10-Year Price/DCF (Projected) Range
Min: 0.38   Max: 97.16
Current: 9.9

0.38
97.16
Price/Median PS Value 2.00
PBH's Price/Median PS Value is ranked higher than
55% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.60 vs. PBH: 2.00 )
PBH' s 10-Year Price/Median PS Value Range
Min: 0.48   Max: 1.76
Current: 2

0.48
1.76
Price/Peter Lynch Fair Value 1.50
PBH's Price/Peter Lynch Fair Value is ranked higher than
92% of the 84 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.00 vs. PBH: 1.50 )
PBH' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.16   Max: 2.27
Current: 1.5

1.16
2.27
Earnings Yield (Greenblatt) 4.90
PBH's Earnings Yield (Greenblatt) is ranked higher than
69% of the 72 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.90 vs. PBH: 4.90 )
PBH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.8   Max: 13.7
Current: 4.9

4.8
13.7
Forward Rate of Return (Yacktman) 20.92
PBH's Forward Rate of Return (Yacktman) is ranked higher than
86% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.16 vs. PBH: 20.92 )
PBH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 4.6   Max: 29.2
Current: 20.92

4.6
29.2

Analyst Estimate

Mar15 Mar16
Revenue(Mil) 698 801
EPS($) 1.81 2.20
EPS without NRI($) 1.81 2.20

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:LRLCY, KMB, RBGPF, EL, UNLRY » details
Traded in other countries:PBV.Germany,
Prestige Brands Holdings Inc is incorporated in the State of Delaware in 1996. The Company sells healthcare, household cleaning and personal care products in North America. It conducts its operations through two main business segments Over-the-Counter Healthcare and Household Cleaning. The Company's portfolio of Over-the-Counter (OTC) Healthcare products includes 14 core brands, including five from the GSK Brands acquisitions. Its core OTC brands are Chloraseptic sore throat remedies, Clear Eyes eye drops, Compound W wart removers, Little Remedies and PediaCare pediatric healthcare products, The Doctor's brand of oral care products, Efferdent and Effergrip denture products, Luden's drops, Dramamine motion sickness products, BC and Goody's analgesic powders, Beano gas prevention, Gaviscon antacids, and Debrox ear drops. Its other significant brands include Dermoplast first-aid products, Murine eye and ear care products, NasalCrom allergy prevention relief product, New-Skin liquid bandage, Wartner wart removers, Fiber Choice fiber laxative supplements, and Ecotrin aspirin. The Company's portfolio of household cleaning brands includes the Comet, Chore Boy and Spic and Span brands. Comet was originally introduced in 1956 and is recognized household cleaning brands. Chore Boy scrubbing pads and sponges were initially launched in the 1920's. Chore Boy products are currently sold in food and drugs stores, mass merchandisers, and in hardware and convenience stores. Competitors in the OTC Healthcare category include Johnson & Johnson; McNeil-PPC Tylenol(r) and Novartis Consumer Healthcare, each of which competes with its PediaCare and Little Remedies brands; The Procter & Gamble Company, maker of Vicks(r), and Reckitt Benckiser, maker of Cepacol(r), each of which competes with its Chloraseptic brand; Kraft Foods, maker of Halls(r), which competes with ourLuden's brand; The Procter & Gamble Company, maker of Fixodent(r), and GlaxoSmithKline, maker of Polident(r), each of which competes with its Efferdent brand; and Insight Pharmaceuticals, Inc., maker of Bonine(r), which competes with its Dramamine brand. Sunstar America, Inc., maker of the GUM(r) line of oral care products, as well as DenTek(r) Oral Care, Inc., which markets a dental protector for nighttime teeth grinding and interdental toothpicks, competes with its The Doctor's oral care brand. Competitors in the Household Cleaning category include: Henkel AG & Co., maker of Ajax(r) Cleanser, and The Clorox Company, maker of Tilex(r), each of which competes with its Comet brand. Additionally, Clorox's Pine Sol(r) and The Procter & Gamble Company's Mr. Clean(r) compete with its Spic and Span brand, while 3M Company, maker of Scotch-Brite(r),O-Cel-O(r) and Dobie(r) brands, and Clorox's SOS(r), compete with its Chore Boy brand. The Company is subject to a variety of other regulations in various foreign markets, including regulations pertaining to import/export regulations and antitrust iss
» More Articles for PBH

Headlines

Articles On GuruFocus.com
Earnings Upward Reaction: Prestige Brands Holdings (PBH), Proto Labs (PRLB) Feb 05 2015 
Meridian Funds Comments on Prestige Brands Sep 08 2014 
Meridian Growth Fund Second Quarter 2014 Commentary Sep 08 2014 
Paulson Bets Again On Mallinckrodt Aug 07 2014 
Private Capital Management Sells Update Nov 27 2013 
Gold Guru John Paulson Drops Gold ABX in First Quarter Sells May 18 2013 
comment on PBH Jan 10 2013 
comment on PBH Jan 10 2013 
Weekly CEO Sells Highlight: Smiths News, Prestige Brands Holdings, Proto Labs, Imax Corp Nov 26 2012 
Why I'd Never Pay More Than Book Value for Nokia (NOK) Apr 12 2012 

More From Other Websites
Prestige Brands Holdings, Inc. to Release Fiscal 2015 Fourth Quarter and Year-End Earnings on May... Apr 09 2015
Prestige Brands Holdings, Inc. to Release Fiscal 2015 Fourth Quarter and Year-End Earnings on May... Apr 09 2015
Goody’s Revs Up Partnership With NASCAR’s Dale Earnhardt Jr. Apr 09 2015
Want A Self-Driving Car? Stock Up On The Dramamine Apr 08 2015
Picture Changes For Consumer Sector And Helen Of Troy Mar 23 2015
Biogen, Five Other Top Stocks Show No Sign Of Slowing Mar 20 2015
This Top Stock Is Ripe For A Buyout Or Acquisition Mar 13 2015
Blue Chips Pace Up Session; All Eyes On Apple Watch Mar 09 2015
Goody’s®, PediaCare® and Little Remedies® Launch Interactive Consumer Loyalty Program Mar 03 2015
PRESTIGE BRANDS HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements... Feb 26 2015
PRESTIGE BRANDS HOLDINGS, INC. Financials Feb 12 2015
10-Q for Prestige Brands Holdings, Inc. Feb 07 2015
Prestige Brands Holdings Inc Earnings Call scheduled for 8:30 am ET today Feb 05 2015
Q3 2015 Prestige Brands Holdings Inc Earnings Release - Before Market Open Feb 05 2015
Prestige Brands beats Street 3Q forecasts Feb 05 2015
Prestige Brands beats Street 3Q forecasts Feb 05 2015
Prestige Brands Holdings, Inc. Reports Fiscal Third Quarter 2015 and Year-to-Date Results Feb 05 2015
PRESTIGE BRANDS HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 05 2015
Prestige Brands Holdings, Inc. Reports Fiscal Third Quarter 2015 and Year-to-Date Results Feb 05 2015
Central Garden & Pet's Q1 Loss Narrower than Expected - Analyst Blog Feb 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK